Explore this development in metastatic melanoma treatment with the FDA’s accelerated approval of TIL therapy, a promising approach for patients who have exhausted other options.

In an era where personalized treatment is paramount, the evolving landscape of axillary management in breast cancer stresses the shift towards minimizing surgical intervention while ensuring optimal patient outcomes.

The recent uncovering of KSHV’s method of commandeering cell metabolism for cancer progression not only highlights a novel therapeutic target but also emphasizes the need for vigilant monitoring in immunocompromised patients, where such viral activations are more likely to precipitate aggressive cancers.

In the evolving landscape of radiation oncology, the discussion around supervision models—direct or virtual—presents a pivotal moment for the field. This debate not only impacts patient access and safety but also stresses upon the profession’s adaptability in integrating technology while preserving core clinical standards.

In the evolving landscape of colorectal cancer screening, recent evidence suggests a critical reevaluation of the benefits and risks of routine surveillance colonoscopies in patients over 70, emphasizing the importance of individualized patient care.

In a recent phase 2–3 trial, nirmatrelvir–ritonavir did not significantly shorten the time to COVID-19 symptom resolution compared to placebo, yet it demonstrated a trend towards reduced hospitalization and death rates, emphasizing the importance of tailored treatment strategies.